Back
Compare AU
Compare MVW vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Australian Equal Weight ETF (MVW) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
MVW | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 251 | 77 |
Median incremental investment | $843.58 | $738.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,787.19 | $1,620.45 |
Average age group | > 35 | > 35 |
Key Summary
MVW | DRUG | |
|---|---|---|
Strategy | The fund seeks to track the performance of the MVIS Australia Equal Weight Index before additional fees. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Nextdc Ltd (1.80 %) Dyno Nobel Ltd (1.64 %) Worley Ltd (1.63 %) | CHF - SWISS FRANC (0 %) BRL - BRAZILIAN REAL (0 %) AUD - AUSTRALIA DOLLAR (0 %) |
Top 3 industries | Materials (32.40 %) Energy (30.06 %) Consumer Staples (19.56 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | Australia (100.00 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.35 % | 0.57 % |
Key Summary
MVW | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | MVIS Australia Equal Weight Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.35 % | 0.57 % |
Price | $37.25 | $8.34 |
Size | $3.206 billion | $162.444 million |
10Y return | 58.58 % | N/A |
Annual distribution yield (5Y) | 3.74 % | 1.92 % |
Market | ASX | ASX |
First listed date | 06/03/2014 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
MVW | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 251 | 77 |
Median incremental investment | $843.58 | $738.73 |
Median investment frequency | Monthly | Monthly |
Median total investment | $4,787.19 | $1,620.45 |
Average age group | > 35 | > 35 |
Pros and Cons
MVW | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
MVW | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |